A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
Clinical trial NCT05649761 · UNKNOWN
Trial details
- NCT number
- NCT05649761
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2020-07-10
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.